audio

Auteur

Bogner Jr

Œuvres

Changes in lipid profiles after switching to a protease inhibitor-containing cART - unfavourable effect of fosamprenavir in obese patients
Category

Documents

Changes in lipid profiles after switching to a protease inhibitor-containing cART - unfavourable effect of fosamprenavir in obese patients

Gyalrong-Steur M, Bogner Jr, Seybold, Seybold U

Changes in lipid profiles after switching to a protease inhibitor-containing cART - unfavourable effect of fosamprenavir in obese patients Alternate Text
Category

Documents

Savoirs

Changes in lipid profiles after switching to a protease inhibitor-containing cART - unfavourable effect of fosamprenavir in obese patients

Gyalrong-Steur M, Bogner Jr, Seybold, Seybold U

Book

8 pages

Flag

English

Impaired CD4-cell immune reconstitution upon HIV therapy in patients with toxoplasmic encephalitis compared to patients with pneumocystis pneumonia as AIDS indicating disease
Category

Documents

Impaired CD4-cell immune reconstitution upon HIV therapy in patients with toxoplasmic encephalitis compared to patients with pneumocystis pneumonia as AIDS indicating disease

Kastenbauer U, Kollan C, Hamouda O, Bogner Jr, The, Wolfe

Impaired CD4-cell immune reconstitution upon HIV therapy in patients with toxoplasmic encephalitis compared to patients with pneumocystis pneumonia as AIDS indicating disease Alternate Text
Category

Documents

Savoirs

Impaired CD4-cell immune reconstitution upon HIV therapy in patients with toxoplasmic encephalitis compared to patients with pneumocystis pneumonia as AIDS indicating disease

Kastenbauer U, Kollan C, Hamouda O, Bogner Jr, The, Wolfe

Book

6 pages

Flag

English

Cost impact of prospective HLA-B*5701-screening prior to abacavir/lamivudine fixed dose combination use in Germany
Category

Documents

Cost impact of prospective HLA-B*5701-screening prior to abacavir/lamivudine fixed dose combination use in Germany

Blankenburg M, Bogner Jr, Becker W, Gorriahn D, Mueller Mc, Jaeger H, Welte R, Baudewig M, Walli R, Stoll M, Wolfe

Cost impact of prospective HLA-B*5701-screening prior to abacavir/lamivudine fixed dose combination use in Germany Alternate Text
Category

Documents

Savoirs

Cost impact of prospective HLA-B*5701-screening prior to abacavir/lamivudine fixed dose combination use in Germany

Blankenburg M, Bogner Jr, Becker W, Gorriahn D, Mueller Mc, Jaeger H, Welte R, Baudewig M, Walli R, Stoll M, Wolfe

Book

7 pages

Flag

English

Alternate Text